Sphera Funds Management’s Precision BioSciences DTIL Stock Holding History

Sphera Funds Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	40,000 -356,116	-90%	-$1.64M	0.03%	94
2025 Q4	$1.65M	Buy	+396,116	New	+$2.25M	0.32%	79
2020 Q2	–	Sell	-4,912	Closed	-$889K	–	97
2020 Q1	$889K	Sell	4,912 -11,546	-70%	-$3.02M	0.11%	64
2019 Q4	$6.86M	Buy	16,458 +4,291	+35%	+$1.35M	0.57%	39
2019 Q3	$3.06M	Buy	12,167 +1,000	+9%	+$325K	0.47%	58
2019 Q2	$4.44M	Buy	11,167 +3,667	+49%	+$1.48M	0.61%	50
2019 Q1	$4.04M	Buy	+7,500	New	+$3.98M	0.37%	65

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Sphera Funds Management's DTIL Position: Q1 2026 in Review

Sphera Funds Management reduced its Precision BioSciences (DTIL) stake by 90% in Q1 2026, selling an estimated $1.64M and leaving 40,000 shares worth $220K. The position accounts for 0.03% of the portfolio, ranked #94.

Sphera Funds Management first reported a position in DTIL in Q1 2019 and has held it in 7 quarters since. The position peaked at $6.86M in Q4 2019. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Sphera Funds Management held 40,000 shares of Precision BioSciences worth $220K as of Q1 2026.
Sphera Funds Management sold 356,116 Precision BioSciences shares in Q1 2026, an estimated $1.64M.
Precision BioSciences made up 0.03% of Sphera Funds Management's portfolio in Q1 2026, its #94 holding.
Sphera Funds Management first reported a position in Precision BioSciences in Q1 2019 and has held it in 7 quarters since.
Sphera Funds Management's Precision BioSciences position peaked at $6.86M in Q4 2019.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.